Using Dichoptic Therapy to Treat Intermittent Exotropia

Status: Recruiting
Location: See location...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Intermittent exotropia is difficult to treat. The mainstay of treatment involves surgery, and in one long-term study authors found that as many as 60% of IXT required at least one re-operation.Patching of the non-dominant eye has also been tested in a large, multi-center randomized control trial and was not found to have a large benefit. More non-surgical treatment modalities are critical to improve the care in this condition.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Maximum Age: 7
Healthy Volunteers: f
View:

• Diagnosed with IXT

• one eye that is their preferred eye

• ages 4-7

• distance control scores of \<= 4

Locations
United States
Virginia
Virginia Commonwealth University
RECRUITING
Richmond
Contact Information
Primary
Evan Silverstein
evan.silverstein@vcuhealth.org
804-828-2467
Backup
Emilia Varrone
emilia.varrone@vcuhealth.org
804-828-9315
Time Frame
Start Date: 2024-07-26
Estimated Completion Date: 2026-06
Participants
Target number of participants: 20
Treatments
Experimental: Luminopia VR headset treatment
Using Dichoptic Therapy to Improve Intermittent Exotropia Control in children ages 4-7
Related Therapeutic Areas
Sponsors
Leads: Virginia Commonwealth University

This content was sourced from clinicaltrials.gov